Ben Tre Pharmaceutical JSC (HOSE:DBT)

Vietnam · Delayed Price · Currency is VND

12,500

-200 (-1.57%)

At close: Jul 3, 2026

12.39% (1Y)

Market Cap	274.59B +14.3%
Revenue (ttm)	860.31B -0.9%
Net Income	12.85B -2.6%
EPS	614.00 -13.1%
Shares Out	21.97M
PE Ratio	20.36
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,802
Open	12,200
Previous Close	12,700
Day's Range	12,000 - 12,550
52-Week Range	9,990 - 13,650
Beta	0.43
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About HOSE:DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant... [Read more]

Industry Pharmaceutical Preparations

Founded 1963

Employees 683

Stock Exchange Ho Chi Minh Stock Exchange

Ticker Symbol DBT

Full Company Profile

Financial Performance

In 2025, HOSE:DBT's revenue was 860.31 billion, a decrease of -0.93% compared to the previous year's 868.41 billion. Earnings were 12.85 billion, a decrease of -2.66%.

Financial Statements